BRUSSELS--(BUSINESS WIRE)--Anheuser-Busch InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD):
Regulated information1
“Cheers to beer – our performance this quarter reflects the strength of the beer category and the consistent execution of our strategy. Through investment in our megabrands and mega platforms, innovation and offering more choices across more occasions, we are strengthening the cultural relevance of our brands with consumers. Thank you to our colleagues for their commitment and disciplined execution, which position us well to continue our momentum.” – Michel Doukeris, CEO, AB InBev
| Revenue +5.6% Revenue increased by 5.6% in 2Q26 with revenue per hl growth of 4.2% and by 5.7% in HY26 with revenue per hl growth of 4.3%.
Reported revenue increased by 11.0% in 2Q26 to 16 660 million USD and by 11.5% in HY26 to 31 927 million USD, positively impacted by currency translation.
6.2% increase in combined revenues of megabrands in 2Q26, led by Corona, which grew by 17% outside of its home market. 27% increase in revenue of no-alcohol beer in 2Q26. 44% increase in revenue of Beyond Beer in 2Q26. 50% increase in Gross Merchandise Value (GMV) from sales of third-party products through BEES Marketplace to reach 1.2 billion USD in 2Q26. Volumes +0.9% Volumes increased by 0.9% in 2Q26, with beer volumes up by 1.1% and non-beer volumes down by 1.1%. Volumes increased by 0.8% in HY26, with beer volumes up by 1.2% and non-beer volumes down by 1.5%.
| Normalized EBITDA +5.8% Normalized EBITDA increased by 5.8% to 5 938 million USD in 2Q26, with a margin expansion of 4bps to 35.6%. Normalized EBITDA increased by 5.6% to 11 375 million USD in HY26, with a margin contraction of 5bps to 35.6%.
Underlying Profit 2 390 million USD Underlying Profit was 2 390 million USD in 2Q26 compared to 1 950 million USD in 2Q25 and was 4 314 million USD in HY26 compared to 3 556 million USD in HY25. Reported profit attributable to equity holders of AB InBev was 3 751 million USD in 2Q26 compared to 1 676 million USD in 2Q25, and was 6 314 million in HY26 compared to 3 824 million in HY25, with HY25, 2Q26 and HY26 positively impacted by non-underlying items.
Underlying EPS 1.21 USD Underlying EPS increased by 23.4% to 1.21 USD in 2Q26, compared to 0.98 USD in 2Q25, and increased by 22.1% to 2.18 USD in HY26, compared to 1.79 USD in HY25. On a constant currency basis, Underlying EPS increased by 12.9% in 2Q26 and by 11.0% in HY26. |
| Net Debt to EBITDA 2.86x Net debt to normalized EBITDA ratio was 2.86x at 30 June 2026 compared to 3.27x at 30 June 2025 and 2.87x at 31 December 25. | |
The 2026 Half Year Financial Report is available on our website at www.ab-inbev.com.
| 1The enclosed information constitutes regulated information as defined in the Belgian Royal Decree of 14 November 2007 regarding the duties of issuers of financial instruments which have been admitted for trading on a regulated market. For important disclaimers and notes on the basis of preparation, please refer to page 15. |
Management comments
Consistent and compounding growth with beer volume up by 1.1% and a 23.4% Underlying EPS increase
The momentum of our business continued in 2Q26, with broad-based volume growth and a 23.4% increase in Underlying EPS. While the consumer environment remains dynamic, consistent execution of our strategy and investment in our megabrands and mega platforms enabled solid top- and bottom-line results. We strengthened our portfolio brand power and estimate that we gained market share across our footprint, maintaining or gaining share in 70% of our markets.
Revenue increased by 5.6%, with total volume growth of 0.9% and a revenue per hl increase of 4.2%, driven by revenue management and positive mix from premiumization and Beyond Beer. Beer volumes grew by 1.1%, with record high second quarter volumes in Mexico, Colombia, and Ecuador. Beer volumes in Brazil returned to growth, and in the US we delivered continued top-line growth and market share gains in both beer and Beyond Beer.
EBITDA increased by 5.8% with flattish margins as overhead management enabled increased sales and marketing investment and offset transactional FX headwinds. Free cash flow increased by 2.5 billion USD versus HY25 to 3.9 billion USD, driven by disciplined execution and the continued optimization of our business.
Key highlights from the quarter included: global megabrand momentum, with Corona, Stella Artois and Michelob Ultra growing revenue by 17%, 19% and 21%, respectively, outside of their home markets; successful activation of the FIFA World Cup across our markets, supporting growth of Michelob Ultra in the US and providing a platform to expand the brand across key markets in Latin America; no-alcohol beer revenue growth of 27%, Beyond Beer revenue growth of 44%, and BEES Marketplace GMV growth of 50% to 1.2 billion USD.
Progressing our strategic priorities
We are executing on three key strategic pillars to deliver consistent growth and long-term value creation.
(1) Lead and grow the category:
We strengthened our portfolio brand power and estimate that we gained or maintained share in 70% of our markets in 2Q26.
(2) Digitize and monetize our ecosystem:
BEES Marketplace GMV increased by 50% versus 2Q25 to 1.2 billion USD from third-party products. Overall BEES GMV increased by 16% versus 2Q25 to 15.0 billion USD.
(3) Optimize our business:
We continued to strengthen our balance sheet, with net debt to EBITDA improving to 2.86x as of 30 June 2026 from 3.27x as of 30 June 2025.
(1) Lead and grow the category
Investment in our megabrands and mega platforms continued to build portfolio brand power, with sales and marketing investment reaching 4.1 billion USD in HY26, up 9% versus HY25. According to the Kantar BrandZ 2026 report, our portfolio holds 8 of the top 10 most valuable beer brands in the world, with Corona and Budweiser ranked #1 and #2, respectively. Our mega platforms strengthened the cultural relevance of our brands during some of the world’s largest moments of celebration, including the Winter Olympics, Roland Garros, Wimbledon and the FIFA World Cup. Across these occasions, our portfolio achieved the #1 share of digital engagement and generated 850 million consumer engagements on social media. Our marketing capabilities were recognized as we were named the Cannes Lions 2026 Creative Marketer of the Year, making us the only company in history to receive this recognition three times.
We continued to execute on our category expansion levers and estimate that the number of legal drinking age consumers purchasing our portfolio increased in HY26 with gains in Beyond Beer and Balanced Choices.
(2) Digitize and monetize our ecosystem
(3) Optimize our business
Continued momentum and reliable compounding growth
In HY26, our business delivered 5.7% revenue growth, 5.6% EBITDA growth and a 22.1% increase in Underlying EPS, driven by beer volume growth, revenue and cost management capabilities, and positive mix. We strengthened our portfolio brand power through investment in our megabrands and mega platforms, scaling our innovations and providing more choices across more occasions. Performance across our megabrands, Balanced Choices, Beyond Beer and BEES Marketplace reflects the strength of our portfolio and the consistent execution of our strategy.
The continued momentum of our business, disciplined execution by our teams and the strength of the beer category reinforce our confidence in our ability to deliver our FY26 outlook and create a future with more cheers.
2026 Outlook
(i) Overall Performance: We expect our EBITDA to grow in line with our medium-term outlook of between 4-8%. The outlook for FY26 reflects our current assessment of inflation and other macroeconomic conditions.
(ii) Net Finance Costs: Net pension interest expenses and accretion expenses are expected to be in the range of 190 to 220 million USD per quarter, depending on currency and interest rate fluctuations. We expect the average gross debt coupon in FY26 to be approximately 4%.
(iii) Effective Tax Rate (ETR): We expect the normalized ETR in FY26 to be in the range of 26% to 28%. The ETR outlook does not consider the impact of potential future changes in legislation.
(iv) Net Capital Expenditure: We expect net capital expenditure of between 3.5 and 4.0 billion USD in FY26.
| Figure 1. Consolidated performance | |||||||||
| in USD Mio, except EPS in USD per share and Volumes in thousand hls | 2Q25 | 2Q26 | Organic | ||||||
| growth | |||||||||
| Volumes | 143 347 |
| 144 003 |
| 0.9 | % | |||
| Beer | 125 620 |
| 126 945 |
| 1.1 | % | |||
| Non-Beer | 17 727 |
| 17 058 |
| (1.1 | )% | |||
| Revenue | 15 004 |
| 16 660 |
| 5.6 | % | |||
| Gross profit | 8 446 |
| 9 579 |
| 7.5 | % | |||
| Gross margin | 56.3 | % | 57.5 | % | 99bps | ||||
| Normalized EBITDA | 5 301 |
| 5 938 |
| 5.8 | % | |||
| Normalized EBITDA margin | 35.3 | % | 35.6 | % | 4bps | ||||
| Normalized EBIT | 4 013 |
| 4 604 |
| 8.0 | % | |||
| Normalized EBIT margin | 26.7 | % | 27.6 | % | 58bps | ||||
|
| |||||||||
| Profit attributable to equity holders of AB InBev | 1 676 |
| 3 751 |
| |||||
| Underlying Profit | 1 950 |
| 2 390 |
| |||||
|
| |||||||||
| Basic EPS | 0.84 |
| 1.90 |
| |||||
| Underlying EPS | 0.98 |
| 1.21 |
|
| ||||
| HY25 | HY26 | Organic | |||||||
| growth | |||||||||
| Volumes | 279 615 |
| 280 412 |
| 0.8 | % | |||
| Beer | 243 005 |
| 245 426 |
| 1.2 | % | |||
| Non-Beer | 36 611 |
| 34 987 |
| (1.5 | )% | |||
| Revenue | 28 632 |
| 31 927 |
| 5.7 | % | |||
| Gross profit | 16 029 |
| 18 225 |
| 7.4 | % | |||
| Gross margin | 56.0 | % | 57.1 | % | 88bps | ||||
| Normalized EBITDA | 10 156 |
| 11 375 |
| 5.6 | % | |||
| Normalized EBITDA margin | 35.5 | % | 35.6 | % | (5)bps | ||||
| Normalized EBIT | 7 601 |
| 8 677 |
| 7.6 | % | |||
| Normalized EBIT margin | 26.5 | % | 27.2 | % | 46bps | ||||
|
| |||||||||
| Profit attributable to equity holders of AB InBev | 3 824 |
| 6 314 |
| |||||
| Underlying Profit | 3 556 |
| 4 314 |
| |||||
|
| |||||||||
| Basic EPS | 1.92 |
| 3.20 |
| |||||
| Underlying EPS | 1.79 |
| 2.18 |
|
| ||||
| Figure 2. Volumes | ||||||||||||||||
| in thousand hls | 2Q25 | Scope | Organic | 2Q26 | Organic growth | |||||||||||
| growth | Total | Beer | ||||||||||||||
| North America | 22 376 | 218 |
| (164 | ) | 22 430 | (0.7 | )% | (0.8 | )% | ||||||
| Middle Americas | 38 822 | (634 | ) | 1 806 |
| 39 994 | 4.7 | % | 4.8 | % | ||||||
| South America | 34 199 | - |
| 466 |
| 34 665 | 1.4 | % | 3.9 | % | ||||||
| EMEA | 24 172 | (135 | ) | 201 |
| 24 239 | 0.8 | % | 0.9 | % | ||||||
| Asia Pacific | 23 716 | (21 | ) | (1 109 | ) | 22 586 | (4.7 | )% | (4.7 | )% | ||||||
| Global Export and Holding Companies | 62 | 14 |
| 12 |
| 89 | 16.3 | % | 16.3 | % | ||||||
| AB InBev Worldwide | 143 347 | (557 | ) | 1 213 |
| 144 003 | 0.9 | % | 1.1 | % | ||||||
| HY25 | Scope | Organic | HY26 | Organic growth | ||||||||||||
| growth | Total | Beer | ||||||||||||||
| North America | 42 218 | 121 |
| (779 | ) | 41 561 | (1.8 | )% | (1.9 | )% | ||||||
| Middle Americas | 73 903 | (1 362 | ) | 3 439 |
| 75 979 | 4.7 | % | 5.2 | % | ||||||
| South America | 75 089 | - |
| 341 |
| 75 430 | 0.5 | % | 2.2 | % | ||||||
| EMEA | 44 924 | (230 | ) | 476 |
| 45 169 | 1.1 | % | 1.2 | % | ||||||
| Asia Pacific | 43 365 | (39 | ) | (1 192 | ) | 42 134 | (2.8 | )% | (2.7 | )% | ||||||
| Global Export and Holding Companies | 116 | 22 |
| 1 |
| 139 | 0.8 | % | 0.8 | % | ||||||
| AB InBev Worldwide | 279 615 | (1 489 | ) | 2 286 |
| 280 412 | 0.8 | % | 1.2 | % | ||||||
Key Markets Performance
United States: Portfolio momentum drove beer and Beyond Beer share gains and continued top-line growth
Mexico: Market share gain and margin expansion drove mid-single digit top- and high-single digit bottom-line growth
Colombia: Record high volumes drove double-digit top- and bottom-line growth
Brazil: Market share gain and an improved industry drove beer volume growth and a double-digit bottom-line increase
Europe: Volume growth and premiumization drove a low-single digit top-line increase
South Africa: Disciplined revenue management and margin expansion drove mid-single digit top- and bottom-line growth
China: Top- and bottom-line declined, impacted by volume performance in a soft industry
Highlights from our other markets
Consolidated Income Statement
| Figure 3. Consolidated income statement | |||||||||
| in USD Mio | 2Q25 | 2Q26
| Organic | ||||||
| growth | |||||||||
| Revenue | 15 004 |
| 16 660 |
| 5.6 | % | |||
| Cost of sales | (6 558 | ) | (7 082 | ) | (3.2 | )% | |||
| Gross profit | 8 446 |
| 9 579 |
| 7.5 | % | |||
| SG&A | (4 624 | ) | (5 175 | ) | (6.5 | )% | |||
| Other operating income/(expenses) | 191 |
| 200 |
| (7.9 | )% | |||
| Normalized EBIT | 4 013 |
| 4 604 |
| 8.0 | % | |||
| Non-underlying items above EBIT | (45 | ) | (42 | ) | |||||
| Net finance income/(expense) | (1 062 | ) | (1 057 | ) | |||||
| Non-underlying net finance income/(expense) | (234 | ) | 1 402 |
| |||||
| Share of results of associates | 84 |
| 96 |
| |||||
| Non-underlying share of results of associates | 9 |
| - |
| |||||
| Income tax expense | (741 | ) | (918 | ) | |||||
| Profit | 2 024 |
| 4 084 |
| |||||
| Profit attributable to non-controlling interest | 347 |
| 333 |
| |||||
| Profit attributable to equity holders of AB InBev | 1 676 |
| 3 751 |
| |||||
| Normalized EBITDA | 5 301 |
| 5 938 |
| 5.8 | % | |||
| Underlying Profit | 1 950 |
| 2 390 |
|
| ||||
| HY25 | HY26 | Organic | |||||||
| growth | |||||||||
| Revenue | 28 632 |
| 31 927 |
| 5.7 | % | |||
| Cost of sales | (12 602 | ) | (13 702 | ) | (3.6 | )% | |||
| Gross profit | 16 029 |
| 18 225 |
| 7.4 | % | |||
| SG&A | (8 812 | ) | (9 917 | ) | (6.5 | )% | |||
| Other operating income/(expenses) | 383 |
| 369 |
| (9.7 | )% | |||
| Normalized EBIT | 7 601 |
| 8 677 |
| 7.6 | % | |||
| Non-underlying items above EBIT | (94 | ) | 14 |
| |||||
| Net finance income/(expense) | (2 046 | ) | (2 107 | ) | |||||
| Non-underlying net finance income/(expense) | 368 |
| 2 033 |
| |||||
| Share of results of associates | 135 |
| 148 |
| |||||
| Non-underlying share of results of associates | 9 |
| - |
| |||||
| Income tax expense | (1 404 | ) | (1 704 | ) | |||||
| Profit | 4 568 |
| 7 061 |
| |||||
| Profit attributable to non-controlling interest | 744 |
| 747 |
| |||||
| Profit attributable to equity holders of AB InBev | 3 824 |
| 6 314 |
| |||||
| Normalized EBITDA | 10 156 |
| 11 375 |
| 5.6 | % | |||
| Underlying Profit | 3 556 |
| 4 314 |
|
| ||||
Non-underlying items above EBIT & Non-underlying share of results of associates
| Figure 4. Non-underlying items above EBIT & Non-underlying share of results of associates | ||||||||||||
| in USD Mio | 2Q25 | 2Q26 | HY25 | HY26 | ||||||||
| Restructuring | (35 | ) | (11 | ) | (47 | ) | (33 | ) | ||||
| Business and asset disposals (including impairment losses) | (10 | ) | (17 | ) | (47 | ) | 61 |
| ||||
| Acquisition-related costs (business combinations) | - |
| (14 | ) | - |
| (14 | ) | ||||
| Non-underlying items in EBIT | (45 | ) | (42 | ) | (94 | ) | 14 |
| ||||
| Non-underlying share of results of associates | 9 |
| - |
| 9 |
| - |
| ||||
Normalized EBIT excludes negative non-underlying items of 42 million USD in 2Q26 and positive non-underlying items of 14 million USD in HY26.
Net finance income/(expense)
| Figure 5. Net finance income/(expense) | ||||||||||||
| in USD Mio | 2Q25 | 2Q26 | HY25 | HY26 | ||||||||
| Net interest expense | (663 | ) | (583 | ) | (1 284 | ) | (1 196 | ) | ||||
| Accretion expense and interest on pensions | (184 | ) | (196 | ) | (351 | ) | (413 | ) | ||||
| Other financial results | (214 | ) | (278 | ) | (410 | ) | (498 | ) | ||||
| Net finance income/(expense) | (1 062 | ) | (1 057 | ) | (2 046 | ) | (2 107 | ) | ||||
Non-underlying net finance income/(expense)
| Figure 6. Non-underlying net finance income/(expense) | |||||||||
| in USD Mio | 2Q25 | 2Q26 | HY25 | HY26 | |||||
| Mark-to-market | (263 | ) | 1 402 | 339 | 2 033 | ||||
| Gain/(loss) on bond redemption and other | 29 |
| - | 29 | - | ||||
| Non-underlying net finance income/(expense) | (234 | ) | 1 402 | 368 | 2 033 | ||||
Non-underlying net finance income includes mark-to-market gains on derivative instruments entered into in order to hedge our share-based payment programs and shares issued in relation to the combinations with Grupo Modelo and SAB.
The number of shares covered by the hedging of our share-based payment program, the deferred share instrument and the restricted shares are shown below, together with the opening and closing share prices.
| Figure 7. Non-underlying equity derivative instruments | ||||||||
| 2Q25 | 2Q26 | HY25 | HY26 | |||||
| Share price at the start of the period (Euro) | 56.92 | 59.72 | 48.25 | 54.90 | ||||
| Share price at the end of the period (Euro) | 58.24 | 72.66 | 58.24 | 72.66 | ||||
| Number of equity derivative instruments at the end of the period (in million) | 100.5 | 90.5 | 100.5 | 90.5 | ||||
Income tax expense
| Figure 8. Income tax expense | ||||||||
| in USD Mio | 2Q25 | 2Q26 | HY25 | HY26 | ||||
| Income tax expense | 741 | 918 | 1 404 | 1 704 | ||||
| Effective tax rate | 27.7% | 18.7% | 24.1% | 19.8% | ||||
| Normalized effective tax rate | 25.3% | 26.1% | 25.6% | 25.7% | ||||
The HY26 and HY25 effective tax rates were positively impacted by non-taxable gains from derivatives related to the hedging of share-based payment programs and the hedging of the shares issued in a transaction related to the combinations with Grupo Modelo and SAB. The increase in Normalized ETR in HY26 compared to HY25 was primarily due to negative country mix.
Underlying EPS
| Figure 9. Underlying EPS | ||||||||||||
| in USD per share, except number of shares in million | 2Q25 | 2Q26 | HY25 | HY26 | ||||||||
| Normalized EBITDA | 2.67 |
| 3.01 |
| 5.11 |
| 5.76 |
| ||||
| Depreciation, amortization and impairment | (0.65 | ) | (0.68 | ) | (1.28 | ) | (1.37 | ) | ||||
| Normalized EBIT | 2.02 |
| 2.33 |
| 3.82 |
| 4.39 |
| ||||
| Net finance income/(expense) | (0.53 | ) | (0.54 | ) | (1.03 | ) | (1.07 | ) | ||||
| Income tax expense | (0.38 | ) | (0.47 | ) | (0.71 | ) | (0.85 | ) | ||||
| Associates & non-controlling interests | (0.13 | ) | (0.12 | ) | (0.31 | ) | (0.31 | ) | ||||
| Hyperinflation impacts | 0.01 |
| 0.00 |
| 0.02 |
| 0.02 |
| ||||
| Underlying EPS | 0.98 |
| 1.21 |
| 1.79 |
| 2.18 |
| ||||
| Weighted average number of ordinary and restricted shares | 1 989 |
| 1 976 |
| 1 989 |
| 1 976 |
| ||||
Reconciliation of IFRS and Non-IFRS Financial Measures
Profit attributable to equity holders and Underlying Profit
| Figure 10. Underlying Profit | |||||||||||
| in USD Mio | 2Q25 | 2Q26 | HY25 | HY26 | |||||||
| Profit attributable to equity holders of AB InBev | 1 676 | 3 751 |
| 3 824 |
| 6 314 |
| ||||
| Net impact of non-underlying items on profit | 261 | (1 367 | ) | (305 | ) | (2 034 | ) | ||||
| Hyperinflation impacts | 14 | 7 |
| 37 |
| 35 |
| ||||
| Underlying Profit | 1 950 | 2 390 |
| 3 556 |
| 4 314 |
| ||||
Basic and Underlying EPS
| Figure 11. Basic and Underlying EPS | |||||||||||
| in USD per share, except number of shares in million | 2Q25 | 2Q26 | HY25 | HY26 | |||||||
| Basic EPS | 0.84 | 1.90 |
| 1.92 |
| 3.20 |
| ||||
| Net impact of non-underlying items | 0.13 | (0.69 | ) | (0.15 | ) | (1.03 | ) | ||||
| Hyperinflation impacts | 0.01 | 0.00 |
| 0.02 |
| 0.02 |
| ||||
| Underlying EPS | 0.98 | 1.21 |
| 1.79 |
| 2.18 |
| ||||
| FX translation impact | - | (0.10 | ) | - |
| (0.20 | ) | ||||
| Underlying EPS in constant currency | 0.98 | 1.11 |
| 1.79 |
| 1.98 |
| ||||
| Weighted average number of ordinary and restricted shares | 1 989 | 1 976 |
| 1 989 |
| 1 976 |
| ||||
Profit attributable to equity holders and Normalized EBITDA
| Figure 12. Reconciliation of Normalized EBITDA to Profit attributable to equity holders of AB InBev | ||||||||||||
| in USD Mio | 2Q25 | 2Q26 | HY25 | HY26 | ||||||||
| Profit attributable to equity holders of AB InBev | 1 676 |
| 3 751 |
| 3 824 |
| 6 314 |
| ||||
| Non-controlling interests | 347 |
| 333 |
| 744 |
| 747 |
| ||||
| Profit | 2 024 |
| 4 084 |
| 4 568 |
| 7 061 |
| ||||
| Income tax expense | 741 |
| 918 |
| 1 404 |
| 1 704 |
| ||||
| Share of results of associates | (84 | ) | (96 | ) | (135 | ) | (148 | ) | ||||
| Non-underlying share of results of associates | (9 | ) | - |
| (9 | ) | - |
| ||||
| Net finance (income)/expense | 1 062 |
| 1 057 |
| 2 046 |
| 2 107 |
| ||||
| Non-underlying net finance (income)/expense | 234 |
| (1 402 | ) | (368 | ) | (2 033 | ) | ||||
| Non-underlying items above EBIT (incl. impairment losses) | 45 |
| 42 |
| 94 |
| (14 | ) | ||||
| Normalized EBIT | 4 013 |
| 4 604 |
| 7 601 |
| 8 677 |
| ||||
| Depreciation, amortization and impairment | 1 288 |
| 1 335 |
| 2 555 |
| 2 698 |
| ||||
| Normalized EBITDA | 5 301 |
| 5 938 |
| 10 156 |
| 11 375 |
| ||||
Normalized EBITDA, Normalized EBIT and Underlying Profit are non-IFRS financial measures used by AB InBev to reflect the company’s underlying performance. Underlying EPS and constant currency Underlying EPS are non-IFRS financial measures that AB InBev believes are useful to investors because they facilitate comparisons of EPS from period to period.
Normalized EBITDA is calculated by adjusting profit attributable to equity holders of AB InBev to exclude: (i) non-controlling interest; (ii) income tax expense; (iii) share of results of associates; (iv) non-underlying share of results of associates; (v) net finance income or cost; (vi) non-underlying net finance income or cost; (vii) non-underlying items above EBIT; and (viii) depreciation, amortization and impairment.
Underlying Profit is calculated by adjusting profit attributable to equity holders of AB InBev to exclude: (i) non-underlying items and (ii) hyperinflation impacts. Underlying EPS is calculated as Underlying Profit divided by the weighted average number of ordinary and restricted shares. Constant currency Underlying EPS is calculated as Underlying EPS excluding the effects of foreign currency translation by translating current period figures using the exchange rates from the same period in the prior year.
Normalized EBITDA, Normalized EBIT and Underlying Profit are not accounting measures under IFRS and should not be considered as an alternative to profit attributable to equity holders as a measure of operational performance, or an alternative to cash flow as a measure of liquidity. Underlying EPS and constant currency Underlying EPS are not accounting measures under IFRS and should not be considered as alternatives to earnings per share as a measure of operating performance on a per share basis. These non-IFRS financial measures do not have a standard calculation method and AB InBev’s definition of Normalized EBITDA, Normalized EBIT, Underlying Profit, Underlying EPS and constant currency Underlying EPS may not be comparable to that of other companies.
Cash Flows and Financial position
| Figure 13. Cash Flow Statement (million USD) | ||||||
| HY25 | HY26 | |||||
| Operating activities | ||||||
| Profit of the period | 4 568 |
| 7 061 |
| ||
| Interest, taxes and non-cash items included in profit | 5 736 |
| 4 459 |
| ||
| Cash flow from operating activities before changes in working capital and use of provisions | 10 304 |
| 11 520 |
| ||
|
| ||||||
| Change in working capital | (3 655 | ) | (2 355 | ) | ||
| Pension contributions and use of provisions | (278 | ) | (158 | ) | ||
| Interest and taxes (paid)/received | (3 801 | ) | (3 866 | ) | ||
| Dividends received | 135 |
| 101 |
| ||
| Cash flow from/(used in) operating activities | 2 704 |
| 5 241 |
| ||
|
| ||||||
| Investing activities | ||||||
| Net capex | (1 350 | ) | (1 360 | ) | ||
| Sale/(acquisition) and others related to subsidiaries, net of cash | (4 | ) | (757 | ) | ||
| Net proceeds from sale/(acquisition) of other assets | 47 |
| 310 |
| ||
| Cash flow from/(used in) investing activities | (1 306 | ) | (1 807 | ) | ||
|
| ||||||
| Financing activities | ||||||
| Net (repayments of) / proceeds from borrowings | 68 |
| 246 |
| ||
| Dividends paid | (3 147 | ) | (2 596 | ) | ||
| Share buyback | (1 901 | ) | (1 301 | ) | ||
| Payment of lease liabilities | (354 | ) | (364 | ) | ||
| Derivative financial instruments | 114 |
| (319 | ) | ||
| Sale/(acquisition) of non-controlling interests | (314 | ) | (3 389 | ) | ||
| Other financing cash flows | (303 | ) | 219 |
| ||
| Cash flow from/(used in) financing activities | (5 837 | ) | (7 505 | ) | ||
|
| ||||||
| Net increase/(decrease) in cash and cash equivalents | (4 438 | ) | (4 071 | ) | ||
Our free cash flow (defined as cash flow from operating activities less net capex) increased by 2 526 million USD to reach 3 881 million USD in HY26. Our cash and cash equivalents decreased by (4 071) million USD in HY26, compared to a decrease of (4 438) million USD in HY25, with the following movements:
Our net debt increased to 64.2 billion USD as of 30 June 2026 from 60.9 billion USD as of 31 December 2025. Our net debt to normalized EBITDA ratio was 2.86x as of 30 June 2026. Our optimal capital structure is a net debt to normalized EBITDA ratio of around 2x.
We continue to proactively manage our debt portfolio. 98% of our bond portfolio holds a fixed-interest rate, 52% is denominated in currencies other than USD and maturities are well-distributed across the next several years.
As of 30 June 2026, we had total liquidity of 18.1 billion USD, which consisted of 10.1 billion USD available under committed long-term credit facilities and 8.0 billion USD of cash, cash equivalents and short-term investments in debt securities less bank overdrafts.
Notes
To facilitate the understanding of AB InBev’s underlying performance, the analyses of growth, including all comments in this press release, unless otherwise indicated, are based on organic growth and normalized numbers. In other words, financials are analyzed eliminating the impact of changes in currencies on translation of foreign operations, and scope changes. Since 1Q24, the definition of organic revenue growth has been amended to cap the price growth in Argentina to a maximum of 2% per month (26.8% year-over-year). Corresponding adjustments are made to all income statement related items in the organic growth calculations through scope changes. Scope changes also represent the impact of acquisitions and divestitures, the start or termination of activities or the transfer of activities between segments, curtailment gains and losses and year over year changes in accounting estimates and other assumptions that management does not consider as part of the underlying performance of the business. Beer volumes and revenue include primarily beer, no-alcohol beer, other malt-based alcohol beverages and spirits-based beverages. Non-beer volumes and revenue include primarily carbonated soft drinks and energy drinks. In addition, beer and non-beer categories include not only brands that we own or license, but also third-party brands that we brew and sell, and third-party products that we sell through our distribution network. The organic growth of our global brands, Budweiser, Stella Artois, and Corona excludes exports to Australia for which a perpetual license was granted to a third party upon disposal of the Australia operations in 2020. All references per hectoliter (per hl) exclude US non-beverage activities. Whenever presented in this document, all performance measures (EBITDA, EBIT, profit, tax rate, EPS) are presented on a “normalized” basis, which means they are presented before non-underlying items. Non-underlying items are either income or expenses which do not occur regularly as part of the normal activities of the Company. They are presented separately because they are important for the understanding of the underlying sustainable performance of the Company due to their size or nature. Normalized measures are additional measures used by management and should not replace the measures determined in accordance with IFRS as an indicator of the Company’s performance. Effective 1 January 2026, Cervecería Bucanero S.A., a Cuban company in which we indirectly hold a 50% equity interest through our subsidiary Ambev, is accounted for as an associate using the equity method of accounting. The impact of this change in presentation is reflected as a scope change. We are reporting the results from Argentina applying hyperinflation accounting since 3Q18. The IFRS rules (IAS 29) require us to restate the year-to-date results for the change in the general purchasing power of the local currency, using official indices before converting the local amounts at the closing rate of the period. In 2Q26, we reported a negative impact from hyperinflation accounting on the profit attributable to equity holders of AB InBev of 7 million USD. The impact in 2Q26 Basic EPS was less than 0.01 USD. Values in the figures and annexes may not add up, due to rounding. 2Q26 and HY26 EPS is based upon a weighted average of 1 976 million shares compared to a weighted average of 1 989 million shares for 2Q25 and HY25.
Legal disclaimer
This release contains “forward-looking statements”. These statements are based on the current expectations and views of future events and developments of the management of AB InBev and are naturally subject to uncertainty and changes in circumstances. The forward-looking statements contained in this release include statements other than historical facts and include statements typically containing words such as “will”, “may”, “should”, “believe”, “intends”, “expects”, “anticipates”, “targets”, “ambition”, “estimates”, “likely”, “foresees” and words of similar import. All statements other than statements of historical facts are forward-looking statements. You should not place undue reliance on these forward-looking statements, which reflect the current views of the management of AB InBev, are subject to numerous risks and uncertainties about AB InBev and are dependent on many factors, some of which are outside of AB InBev’s control. There are important factors, risks and uncertainties that could cause actual outcomes and results to be materially different, including, but not limited to the risks and uncertainties relating to AB InBev that are described under Item 3.D of AB InBev’s Annual Report on Form 20-F filed with the SEC on 3 March 2026. Many of these risks and uncertainties are, and will be, exacerbated by any further worsening of the global business and economic environment, including as a result of foreign currency exchange rate fluctuations and ongoing geopolitical instability. Other unknown or unpredictable factors could cause actual results to differ materially from those in the forward-looking statements. The forward-looking statements should be read in conjunction with the other cautionary statements that are included elsewhere, including AB InBev’s most recent Form 20-F and other reports furnished on Form 6-K, and any other documents that AB InBev has made public. Any forward-looking statements made in this communication are qualified in their entirety by these cautionary statements and there can be no assurance that the actual results or developments anticipated by AB InBev will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, AB InBev or its business or operations. Except as required by law, AB InBev undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The half year 2026 (HY26) financial data set out in Figure 1 (except for the volume information), Figures 3 to 6, 8, 10, 12 and 13 of this press release have been extracted from the group’s unaudited condensed consolidated interim financial statements as of and for the six-month period ended 30 June 2026, which have been reviewed by our statutory auditors PwC Bedrijfsrevisoren BV/Reviseurs d’Entreprises SRL in accordance with the standards of the Public Company Accounting Oversight Board (United States). The second quarter 2026 (2Q26) financial data set out in Figure 1 (except for the volume information), Figures 3 to 6, 8, 10, 12 and 13, and the financial data included in Figures 7, 9, 11 and 14 of this press release have been extracted from the underlying accounting records as of and for the six-month period ended 30 June 2026. The interim sustainability data set out on page 3 are from unaudited internal databases. These have been calculated on a consistent basis with the group’s consolidated sustainability statements as of and for the twelve months ended 31 December 2025, for which limited assurance was provided by our statutory auditors PwC Bedrijfsrevisoren BV/Reviseurs d’Entreprises SRL in accordance with CSRD. References in this document to materials on our websites, such as www.ab-inbev.com, are included as an aid to their location and are not incorporated by reference into this document.
Conference call and webcast
Investor Conference call and webcast on Thursday, 30 July 2026:
3.00pm Brussels / 2.00pm London / 9.00am New York
Registration details:
Webcast (listen-only mode):
AB InBev 2Q26 Results Webcast
To join by phone, please use one of the following two phone numbers:
Toll-Free: +1-877-407-8029
Toll: +1-201-689-8029
About AB InBev
Anheuser-Busch InBev (AB InBev) is a publicly traded company (Euronext: ABI) based in Leuven, Belgium, with secondary listings on the Mexico (MEXBOL: ANB) and South Africa (JSE: ANH) stock exchanges and with American Depositary Receipts on the New York Stock Exchange (NYSE: BUD). As a company, we dream big to create a future with more cheers. We are always looking to serve up new ways to meet life’s moments, move our industry forward and make a meaningful impact in the world. We are committed to building great brands that stand the test of time and to brewing the best beers using the finest ingredients. Beer is the drink for moderation, and for over a century, AB InBev has championed responsible drinking. We are committed to providing our consumers with Balanced Choices to enjoy on any occasion. We also invest in marketing that aims to reinforce positive behaviors, and we work with communities, customers, and partners to promote responsible consumption through evidence-based initiatives.
Our diverse portfolio of well over 400 beer brands includes global brands Budweiser®, Corona®, Stella Artois® and Michelob Ultra®; multi-country brands Beck’s®, Hoegaarden® and Leffe®; and local champions such as Aguila®, Antarctica®, Bud Light®, Brahma®, Cass®, Castle®, Castle Lite®, Cristal®, Harbin®, Jupiler®, Modelo Especial®, Quilmes®, Victoria®, Sedrin®, and Skol®. Our brewing heritage dates back more than 600 years, spanning continents and generations. From our European roots at the Den Hoorn brewery in Leuven, Belgium. To the pioneering spirit of the Anheuser & Co brewery in St. Louis, US. To the creation of the Castle Brewery in South Africa during the Johannesburg gold rush. To Bohemia, the first brewery in Brazil. Geographically diversified with a balanced exposure to developed and developing markets, we leverage the collective strengths of approximately 137 000 colleagues based in more than 40 countries worldwide. For 2025, AB InBev’s reported revenue was 59.3 billion USD (excluding JVs and associates).
Annex 1: Segment reporting (2Q)
| AB InBev Worldwide | 2Q25 | Scope | Currency | Organic | 2Q26 | Organic | ||||||||||||
| Volumes | 143 347 |
| (557 | ) | - |
| 1 213 |
| 144 003 |
| 0.9 | % | ||||||
| Revenue | 15 004 |
| (6 | ) | 822 |
| 840 |
| 16 660 |
| 5.6 | % | ||||||
| Cost of sales | (6 558 | ) | 13 |
| (326 | ) | (211 | ) | (7 082 | ) | (3.2 | )% | ||||||
| Gross profit | 8 446 |
| 6 |
| 496 |
| 630 |
| 9 579 |
| 7.5 | % | ||||||
| SG&A | (4 624 | ) | (41 | ) | (209 | ) | (300 | ) | (5 175 | ) | (6.5 | )% | ||||||
| Other operating income/(expenses) | 191 |
| 7 |
| 17 |
| (15 | ) | 200 |
| (7.9 | )% | ||||||
| Normalized EBIT | 4 013 |
| (28 | ) | 304 |
| 315 |
| 4 604 |
| 8.0 | % | ||||||
| Normalized EBITDA | 5 301 |
| (34 | ) | 370 |
| 301 |
| 5 938 |
| 5.8 | % | ||||||
| Normalized EBITDA margin | 35.3 | % | 35.6 | % | 4bps | |||||||||||||
| North America | 2Q25 | Scope | Currency | Organic | 2Q26 |
Organic | ||||||||||||
| Volumes | 22 376 |
| 218 |
| - |
| (164 | ) | 22 430 |
| (0.7 | )% | ||||||
| Revenue | 3 844 |
| 90 |
| 7 |
| 99 |
| 4 039 |
| 2.6 | % | ||||||
| Cost of sales | (1 537 | ) | (36 | ) | (2 | ) | (2 | ) | (1 577 | ) | (0.1 | )% | ||||||
| Gross profit | 2 307 |
| 53 |
| 5 |
| 97 |
| 2 463 |
| 4.2 | % | ||||||
| SG&A | (1 122 | ) | (30 | ) | (2 | ) | (77 | ) | (1 232 | ) | (6.9 | )% | ||||||
| Other operating income/(expenses) | 10 |
| 0 |
| (0 | ) | 6 |
| 16 |
| 61.7 | % | ||||||
| Normalized EBIT | 1 195 |
| 23 |
| 3 |
| 26 |
| 1 247 |
| 2.2 | % | ||||||
| Normalized EBITDA | 1 372 |
| 27 |
| 3 |
| 6 |
| 1 408 |
| 0.5 | % | ||||||
| Normalized EBITDA margin | 35.7 | % | 34.9 | % | (74)bps | |||||||||||||
|
| ||||||||||||||||||
| Middle Americas | 2Q25 | Scope | Currency | Organic | 2Q26 | Organic | ||||||||||||
| Volumes | 38 822 |
| (634 | ) | - |
| 1 806 |
| 39 994 |
| 4.7 | % | ||||||
| Revenue | 4 340 |
| (77 | ) | 408 |
| 419 |
| 5 091 |
| 9.8 | % | ||||||
| Cost of sales | (1 516 | ) | 42 |
| (132 | ) | (91 | ) | (1 697 | ) | (6.2 | )% | ||||||
| Gross profit | 2 824 |
| (35 | ) | 276 |
| 328 |
| 3 394 |
| 11.8 | % | ||||||
| SG&A | (987 | ) | 13 |
| (91 | ) | (95 | ) | (1 160 | ) | (9.8 | )% | ||||||
| Other operating income/(expenses) | 3 |
| 1 |
| (1 | ) | (16 | ) | (14 | ) | - |
| ||||||
| Normalized EBIT | 1 839 |
| (21 | ) | 185 |
| 217 |
| 2 220 |
| 11.9 | % | ||||||
| Normalized EBITDA | 2 149 |
| (20 | ) | 211 |
| 220 |
| 2 560 |
| 10.3 | % | ||||||
| Normalized EBITDA margin | 49.5 | % | 50.3 | % | 23bps | |||||||||||||
| South America | 2Q25 | Scope | Currency | Organic | 2Q26 |
Organic | ||||||||||||
| Volumes | 34 199 |
| - |
| - |
| 466 |
| 34 665 |
| 1.4 | % | ||||||
| Revenue | 2 529 |
| 6 |
| 236 |
| 191 |
| 2 961 |
| 7.6 | % | ||||||
| Cost of sales | (1 314 | ) | (14 | ) | (106 | ) | (29 | ) | (1 463 | ) | (2.2 | )% | ||||||
| Gross profit | 1 215 |
| (8 | ) | 130 |
| 162 |
| 1 499 |
| 13.4 | % | ||||||
| SG&A | (863 | ) | (4 | ) | (67 | ) | (78 | ) | (1 012 | ) | (9.0 | )% | ||||||
| Other operating income/(expenses) | 104 |
| 9 |
| 15 |
| 19 |
| 146 |
| 18.7 | % | ||||||
| Normalized EBIT | 456 |
| (4 | ) | 77 |
| 103 |
| 633 |
| 23.0 | % | ||||||
| Normalized EBITDA | 692 |
| 1 |
| 94 |
| 99 |
| 886 |
| 14.3 | % | ||||||
| Normalized EBITDA margin | 27.4 | % | 29.9 | % | 171bps | |||||||||||||
| EMEA | 2Q25 | Scope | Currency | Organic | 2Q26 | Organic | ||||||||||||
| Volumes | 24 172 |
| (135 | ) | - |
| 201 |
| 24 239 |
| 0.8 | % | ||||||
| Revenue | 2 489 |
| (37 | ) | 145 |
| 81 |
| 2 677 |
| 3.3 | % | ||||||
| Cost of sales | (1 252 | ) | 21 |
| (73 | ) | (17 | ) | (1 321 | ) | (1.3 | )% | ||||||
| Gross profit | 1 237 |
| (17 | ) | 72 |
| 65 |
| 1 357 |
| 5.3 | % | ||||||
| SG&A | (764 | ) | (6 | ) | (37 | ) | (35 | ) | (841 | ) | (4.5 | )% | ||||||
| Other operating income/(expenses) | 56 |
| (3 | ) | 1 |
| (15 | ) | 39 |
| (28.9 | )% | ||||||
| Normalized EBIT | 529 |
| (25 | ) | 35 |
| 14 |
| 554 |
| 2.9 | % | ||||||
| Normalized EBITDA | 800 |
| (21 | ) | 51 |
| 13 |
| 843 |
| 1.7 | % | ||||||
| Normalized EBITDA margin | 32.1 | % | 31.5 | % | (49)bps | |||||||||||||
|
| ||||||||||||||||||
| Asia Pacific | 2Q25 | Scope | Currency | Organic | 2Q26 | Organic | ||||||||||||
| Volumes | 23 716 |
| (21 | ) | - |
| (1 109 | ) | 22 586 |
| (4.7 | )% | ||||||
| Revenue | 1 658 |
| 11 |
| 26 |
| (47 | ) | 1 648 |
| (2.8 | )% | ||||||
| Cost of sales | (771 | ) | 1 |
| (9 | ) | 30 |
| (750 | ) | 3.9 | % | ||||||
| Gross profit | 886 |
| 12 |
| 17 |
| (17 | ) | 898 |
| (1.9 | )% | ||||||
| SG&A | (520 | ) | (13 | ) | (7 | ) | (21 | ) | (561 | ) | (4.0 | )% | ||||||
| Other operating income/(expenses) | 17 |
| (0 | ) | 1 |
| (8 | ) | 9 |
| (47.5 | )% | ||||||
| Normalized EBIT | 383 |
| (1 | ) | 11 |
| (46 | ) | 347 |
| (11.9 | )% | ||||||
| Normalized EBITDA | 533 |
| 3 |
| 15 |
| (58 | ) | 493 |
| (10.9 | )% | ||||||
| Normalized EBITDA margin | 32.2 | % | 29.9 | % | (269)bps | |||||||||||||
|
| ||||||||||||||||||
| Global Export and Holding Companies | 2Q25 | Scope | Currency | Organic | 2Q26 | Organic | ||||||||||||
| Volumes | 62 |
| 14 |
| - |
| 12 |
| 89 |
| 16.3 | % | ||||||
| Revenue | 144 |
| 2 |
| 1 |
| 97 |
| 244 |
| 66.1 | % | ||||||
| Cost of sales | (168 | ) | (1 | ) | (4 | ) | (102 | ) | (275 | ) | (60.7 | )% | ||||||
| Gross profit | (23 | ) | 1 |
| (3 | ) | (6 | ) | (32 | ) | (26.3 | )% | ||||||
| SG&A | (368 | ) | (1 | ) | (6 | ) | 6 |
| (369 | ) | 1.6 | % | ||||||
| Other operating income/(expenses) | 2 |
| 0 |
| 2 |
| (0 | ) | 3 |
| (3.7 | )% | ||||||
| Normalized EBIT | (389 | ) | (0 | ) | (7 | ) | (0 | ) | (397 | ) | (0.1 | )% | ||||||
| Normalized EBITDA | (245 | ) | (23 | ) | (5 | ) | 21 |
| (252 | ) | 7.9 | % | ||||||
Annex 2: Segment reporting (HY)
| AB InBev Worldwide | HY25 | Scope | Currency | Organic | HY26 | Organic | ||||||||||||
| Volumes | 279 615 |
| (1 489 | ) | - |
| 2 286 |
| 280 412 |
| 0.8 | % | ||||||
| Revenue | 28 632 |
| (106 | ) | 1 783 |
| 1 618 |
| 31 927 |
| 5.7 | % | ||||||
| Cost of sales | (12 602 | ) | 72 |
| (726 | ) | (446 | ) | (13 702 | ) | (3.6 | )% | ||||||
| Gross profit | 16 029 |
| (34 | ) | 1 058 |
| 1 173 |
| 18 225 |
| 7.4 | % | ||||||
| SG&A | (8 812 | ) | (48 | ) | (486 | ) | (572 | ) | (9 917 | ) | (6.5 | )% | ||||||
| Other operating income/(expenses) | 383 |
| (10 | ) | 32 |
| (35 | ) | 369 |
| (9.7 | )% | ||||||
| Normalized EBIT | 7 601 |
| (92 | ) | 603 |
| 566 |
| 8 677 |
| 7.6 | % | ||||||
| Normalized EBITDA | 10 156 |
| (103 | ) | 766 |
| 557 |
| 11 375 |
| 5.6 | % | ||||||
| Normalized EBITDA margin | 35.5 | % | 35.6 | % | (5)bps | |||||||||||||
| North America | HY25 | Scope | Currency | Organic | HY26 |
Organic | ||||||||||||
| Volumes | 42 218 |
| 121 |
| - |
| (779 | ) | 41 561 |
| (1.8 | )% | ||||||
| Revenue | 7 208 |
| 59 |
| 27 |
| 131 |
| 7 424 |
| 1.8 | % | ||||||
| Cost of sales | (2 947 | ) | (7 | ) | (9 | ) | 30 |
| (2 932 | ) | 1.0 | % | ||||||
| Gross profit | 4 261 |
| 53 |
| 18 |
| 161 |
| 4 492 |
| 3.8 | % | ||||||
| SG&A | (2 174 | ) | (35 | ) | (10 | ) | (108 | ) | (2 328 | ) | (5.0 | )% | ||||||
| Other operating income/(expenses) | 23 |
| (0 | ) | (1 | ) | (4 | ) | 18 |
| (18.5 | )% | ||||||
| Normalized EBIT | 2 110 |
| 18 |
| 7 |
| 48 |
| 2 183 |
| 2.3 | % | ||||||
| Normalized EBITDA | 2 459 |
| 25 |
| 8 |
| 14 |
| 2 505 |
| 0.6 | % | ||||||
| Normalized EBITDA margin | 34.1 | % | 33.7 | % | (43)bps | |||||||||||||
| Middle Americas | HY25 | Scope | Currency | Organic | HY26 | Organic | ||||||||||||
| Volumes | 73 903 |
| (1 362 | ) | - |
| 3 439 |
| 75 979 |
| 4.7 | % | ||||||
| Revenue | 8 124 |
| (155 | ) | 858 |
| 768 |
| 9 595 |
| 9.6 | % | ||||||
| Cost of sales | (2 866 | ) | 83 |
| (283 | ) | (193 | ) | (3 259 | ) | (6.9 | )% | ||||||
| Gross profit | 5 258 |
| (72 | ) | 575 |
| 575 |
| 6 337 |
| 11.1 | % | ||||||
| SG&A | (1 898 | ) | 26 |
| (201 | ) | (167 | ) | (2 241 | ) | (8.9 | )% | ||||||
| Other operating income/(expenses) | 14 |
| 0 |
| (0 | ) | (22 | ) | (7 | ) | - |
| ||||||
| Normalized EBIT | 3 374 |
| (46 | ) | 374 |
| 387 |
| 4 088 |
| 11.6 | % | ||||||
| Normalized EBITDA | 4 007 |
| (44 | ) | 435 |
| 369 |
| 4 767 |
| 9.3 | % | ||||||
| Normalized EBITDA margin | 49.3 | % | 49.7 | % | (15)bps | |||||||||||||
| South America | HY25 | Scope | Currency | Organic | HY26 | Organic | ||||||||||||
| Volumes | 75 089 |
| - |
| - |
| 341 |
| 75 430 |
| 0.5 | % | ||||||
| Revenue | 5 507 |
| 8 |
| 428 |
| 458 |
| 6 402 |
| 8.3 | % | ||||||
| Cost of sales | (2 764 | ) | (17 | ) | (198 | ) | (140 | ) | (3 119 | ) | (5.1 | )% | ||||||
| Gross profit | 2 743 |
| (9 | ) | 230 |
| 318 |
| 3 282 |
| 11.6 | % | ||||||
| SG&A | (1 712 | ) | (8 | ) | (114 | ) | (134 | ) | (1 968 | ) | (7.8 | )% | ||||||
| Other operating income/(expenses) | 201 |
| (2 | ) | 26 |
| 29 |
| 255 |
| 15.3 | % | ||||||
| Normalized EBIT | 1 233 |
| (19 | ) | 142 |
| 213 |
| 1 568 |
| 17.6 | % | ||||||
| Normalized EBITDA | 1 699 |
| (9 | ) | 174 |
| 212 |
| 2 076 |
| 12.5 | % | ||||||
| Normalized EBITDA margin | 30.9 | % | 32.4 | % | 120bps | |||||||||||||
| EMEA | HY25 | Scope | Currency | Organic | HY26 | Organic | ||||||||||||
| Volumes | 44 924 |
| (230 | ) | - |
| 476 |
| 45 169 |
| 1.1 | % | ||||||
| Revenue | 4 454 |
| (69 | ) | 397 |
| 169 |
| 4 951 |
| 3.8 | % | ||||||
| Cost of sales | (2 280 | ) | 38 |
| (202 | ) | (29 | ) | (2 473 | ) | (1.3 | )% | ||||||
| Gross profit | 2 174 |
| (31 | ) | 195 |
| 139 |
| 2 478 |
| 6.5 | % | ||||||
| SG&A | (1 371 | ) | (11 | ) | (121 | ) | (78 | ) | (1 581 | ) | (5.7 | )% | ||||||
| Other operating income/(expenses) | 101 |
| (8 | ) | 4 |
| (23 | ) | 73 |
| (25.1 | )% | ||||||
| Normalized EBIT | 904 |
| (50 | ) | 79 |
| 38 |
| 970 |
| 4.4 | % | ||||||
| Normalized EBITDA | 1 424 |
| (41 | ) | 127 |
| 37 |
| 1 546 |
| 2.7 | % | ||||||
| Normalized EBITDA margin | 32.0 | % | 31.2 | % | (36)bps | |||||||||||||
| Asia Pacific | HY25 | Scope | Currency | Organic | HY26 |
Organic | ||||||||||||
| Volumes | 43 365 |
| (39 | ) | - |
| (1 192 | ) | 42 134 |
| (2.8 | )% | ||||||
| Revenue | 3 108 |
| 10 |
| 70 |
| (66 | ) | 3 122 |
| (2.1 | )% | ||||||
| Cost of sales | (1 456 | ) | 2 |
| (28 | ) | 41 |
| (1 441 | ) | 2.8 | % | ||||||
| Gross profit | 1 652 |
| 12 |
| 42 |
| (25 | ) | 1 681 |
| (1.5 | )% | ||||||
| SG&A | (941 | ) | (12 | ) | (20 | ) | (42 | ) | (1 015 | ) | (4.5 | )% | ||||||
| Other operating income/(expenses) | 41 |
| (1 | ) | 1 |
| (14 | ) | 27 |
| (35.6 | )% | ||||||
| Normalized EBIT | 752 |
| (1 | ) | 24 |
| (82 | ) | 693 |
| (10.9 | )% | ||||||
| Normalized EBITDA | 1 056 |
| 7 |
| 34 |
| (107 | ) | 990 |
| (10.0 | )% | ||||||
| Normalized EBITDA margin | 34.0 | % | 31.7 | % | (277)bps | |||||||||||||
| Global Export and Holding Companies | HY25 | Scope | Currency | Organic | HY26 | Organic | ||||||||||||
| Volumes | 116 |
| 22 |
| - |
| 1 |
| 139 |
| 0.8 | % | ||||||
| Revenue | 231 |
| 40 |
| 3 |
| 159 |
| 433 |
| 68.0 | % | ||||||
| Cost of sales | (290 | ) | (27 | ) | (6 | ) | (155 | ) | (477 | ) | (53.0 | )% | ||||||
| Gross profit | (59 | ) | 13 |
| (3 | ) | 4 |
| (45 | ) | 7.5 | % | ||||||
| SG&A | (716 | ) | (7 | ) | (20 | ) | (42 | ) | (784 | ) | (5.8 | )% | ||||||
| Other operating income/(expenses) | 2 |
| 0 |
| 1 |
| (0 | ) | 3 |
| (19.0 | )% | ||||||
| Normalized EBIT | (773 | ) | 7 |
| (21 | ) | (38 | ) | (826 | ) | (4.9 | )% | ||||||
| Normalized EBITDA | (489 | ) | (40 | ) | (11 | ) | 32 |
| (508 | ) | 6.0 | % | ||||||
Annex 3: Consolidated statement of financial position
| Million US dollar | 31 December 2025 | 30 June 2026 | ||
| . | ||||
| ASSETS | ||||
| Non-current assets | ||||
| Property, plant and equipment | 23 664 | 22 998 | ||
| Goodwill | 117 908 | 119 946 | ||
| Intangible assets | 41 985 | 42 274 | ||
| Investments in associates | 5 002 | 5 061 | ||
| Investment securities | 161 | 166 | ||
| Deferred tax assets | 2 708 | 2 766 | ||
| Pensions and similar obligations | 150 | 154 | ||
| Income tax receivables | 444 | 440 | ||
| Derivatives | 145 | 313 | ||
| Trade and other receivables | 1 871 | 2 026 | ||
| Total non-current assets | 194 039 | 196 143 | ||
|
| ||||
| Current assets | ||||
| Investment securities | 306 | 353 | ||
| Inventories | 5 107 | 5 528 | ||
| Income tax receivables | 785 | 622 | ||
| Derivatives | 583 | 629 | ||
| Trade and other receivables | 6 161 | 7 404 | ||
| Cash and cash equivalents | 11 638 | 7 658 | ||
| Assets classified as held for sale | 190 | 48 | ||
| Total current assets | 24 769 | 22 242 | ||
|
| ||||
| Total assets | 218 808 | 218 385 | ||
|
| ||||
| EQUITY AND LIABILITIES | ||||
| Equity | ||||
| Issued capital | 1 736 | 1 736 | ||
| Share premium | 17 620 | 17 620 | ||
| Reserves | 17 803 | 22 458 | ||
| Retained earnings | 50 128 | 51 686 | ||
| Equity attributable to equity holders of AB InBev | 87 287 | 93 500 | ||
|
| ||||
| Non-controlling interests | 10 449 | 7 685 | ||
| Total equity | 97 736 | 101 185 | ||
|
| ||||
| Non-current liabilities | ||||
| Interest-bearing loans and borrowings | 72 128 | 68 908 | ||
| Pensions and similar obligations | 1 275 | 1 262 | ||
| Deferred tax liabilities | 11 400 | 11 565 | ||
| Income tax payables | 206 | 186 | ||
| Derivatives | 293 | 391 | ||
| Trade and other payables | 869 | 1 028 | ||
| Provisions | 425 | 384 | ||
| Total non-current liabilities | 86 596 | 83 724 | ||
|
| ||||
| Current liabilities | ||||
| Bank overdrafts | 14 | 29 | ||
| Interest-bearing loans and borrowings | 885 | 3 381 | ||
| Income tax payables | 1 825 | 1 235 | ||
| Derivatives | 6 104 | 4 021 | ||
| Trade and other payables | 25 455 | 24 605 | ||
| Provisions | 192 | 205 | ||
| Total current liabilities | 34 475 | 33 476 | ||
|
| ||||
| Total equity and liabilities | 218 808 | 218 385 |
Annex 4: Consolidated statement of cash flows
| For the six-month period ended 30 June | ||||||
| Million US dollar | 2025 | 2026 | ||||
| OPERATING ACTIVITIES | ||||||
| Profit of the period | 4 568 |
| 7 061 |
| ||
| Depreciation, amortization and impairment | 2 581 |
| 2 757 |
| ||
| Net finance (income)/expense | 1 678 |
| 74 |
| ||
| Equity-settled share-based payment expense | 309 |
| 270 |
| ||
| Income tax expense | 1 404 |
| 1 704 |
| ||
| Share of results of associates | (144 | ) | (148 | ) | ||
| Other non-cash items | (93 | ) | (199 | ) | ||
| Cash flow from operating activities before changes in working capital and use of provisions | 10 304 |
| 11 520 |
| ||
| Decrease/(increase) in trade and other receivables | (1 130 | ) | (1 077 | ) | ||
| Decrease/(increase) in inventories | (242 | ) | (370 | ) | ||
| Increase/(decrease) in trade and other payables | (2 284 | ) | (909 | ) | ||
| Pension contributions and use of provisions | (278 | ) | (158 | ) | ||
| Cash generated from operations | 6 370 |
| 9 007 |
| ||
| Interest paid | (1 916 | ) | (1 910 | ) | ||
| Interest received | 241 |
| 243 |
| ||
| Dividends received | 135 |
| 101 |
| ||
| Income tax paid | (2 126 | ) | (2 200 | ) | ||
| Cash flow from/(used in) operating activities | 2 704 |
| 5 241 |
| ||
| INVESTING ACTIVITIES | ||||||
| Acquisition of property, plant and equipment and of intangible assets | (1 404 | ) | (1 406 | ) | ||
| Proceeds from sale of property, plant and equipment and of intangible assets | 55 |
| 46 |
| ||
| Sale/(acquisition) and others related to subsidiaries, net of cash | (4 | ) | (757 | ) | ||
| Proceeds from sale/(acquisition) of other assets | 47 |
| 310 |
| ||
| Cash flow from/(used in) investing activities | (1 306 | ) | (1 807 | ) | ||
| FINANCING ACTIVITIES | ||||||
| Proceeds from borrowings | 4 067 |
| 555 |
| ||
| Repayments of borrowings | (3 998 | ) | (309 | ) | ||
| Dividends paid | (3 147 | ) | (2 596 | ) | ||
| Share buyback | (1 901 | ) | (1 301 | ) | ||
| Payment of lease liabilities | (354 | ) | (364 | ) | ||
| Derivative financial instruments | 114 |
| (319 | ) | ||
| Sale/(acquisition) of non-controlling interests | (314 | ) | (3 389 | ) | ||
| Other financing cash flows | (303 | ) | 219 |
| ||
| Cash flow from/(used in) financing activities | (5 837 | ) | (7 505 | ) | ||
| Net increase/(decrease) in cash and cash equivalents | (4 438 | ) | (4 071 | ) | ||
| Cash and cash equivalents less bank overdrafts at beginning of year | 11 174 |
| 11 623 |
| ||
| Effect of exchange rate fluctuations | 410 |
| 76 |
| ||
| Cash and cash equivalents less bank overdrafts at end of period | 7 146 |
| 7 629 |
| ||
Investors
Shaun Fullalove
E-mail: shaun.fullalove@ab-inbev.com
Ekaterina Baillie
E-mail: ekaterina.baillie@ab-inbev.com
Patrick Ryan
E-mail: patrick.ryan@ab-inbev.com
Media
Media Relations
E-mail: media.relations@ab-inbev.com


Figure 14. Terms and debt repayment schedule as of 30 June 2026 (billion USD)